We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

98 hedge funds and large institutions have $228M invested in Albany Molecular Research Inc in 2013 Q2 according to their latest regulatory filings, with 98 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

49% less call options, than puts

Call options by funds: $317K | Put options by funds: $627K

Holders
98
Holders Change
+98
Holders Change %
–
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
98
Increased
–
Reduced
–
Closed
–
Calls
$317K
Puts
$627K
Net Calls
-$310K
Net Calls Change
-$310K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
51
Jane Street
New York
$658K +$600K +55,418 New
Axa
52
Axa
France
$636K +$581K +53,600 New
D.E. Shaw & Co
53
D.E. Shaw & Co
New York
$610K +$556K +51,370 New
PPA
54
Parametric Portfolio Associates
Washington
$557K +$508K +46,898 New
NI
55
Numeric Investors
Massachusetts
$544K +$496K +45,800 New
First Trust Advisors
56
First Trust Advisors
Illinois
$510K +$465K +42,945 New
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$481K +$439K +40,538 New
Millennium Management
58
Millennium Management
New York
$449K +$409K +37,791 New
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$439K +$401K +36,995 New
Royal Bank of Canada
60
Royal Bank of Canada
Ontario, Canada
$405K +$369K +34,100 New
CBOA
61
Commonwealth Bank of Australia
Australia
$369K +$337K +31,120 New
TA
62
Teachers Advisors
New York
$364K +$332K +30,636 New
Jacobs Levy Equity Management
63
Jacobs Levy Equity Management
New Jersey
$361K +$330K +30,421 New
PCM
64
Prelude Capital Management
New York
$356K +$325K +30,000 New
HIM
65
Hillsdale Investment Management
Ontario, Canada
$316K +$288K +26,600 New
KeyBank National Association
66
KeyBank National Association
Ohio
$309K +$282K +26,011 New
OSAM
67
O'Shaughnessy Asset Management
Connecticut
$278K +$253K +23,360 New
CAM
68
ClariVest Asset Management
California
$272K +$249K +22,947 New
WCM
69
Wedge Capital Management
North Carolina
$258K +$235K +21,700 New
LBC
70
Lawrence B. Cohen
$257K +$235K +21,675 New
JP Morgan Chase
71
JP Morgan Chase
New York
$242K +$220K +20,353 New
MLICM
72
Metropolitan Life Insurance Company (MetLife)
New York
$234K +$214K +19,745 New
Two Sigma Advisers
73
Two Sigma Advisers
New York
$230K +$209K +19,300 New
VOYA Investment Management
74
VOYA Investment Management
Georgia
$221K +$201K +18,589 New
DekaBank Deutsche Girozentrale
75
DekaBank Deutsche Girozentrale
Germany
$202K +$179K +16,500 New
1 2
3
4

AMRI Hedge Fund Activity: Q2 2013 in Review

98 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2013, worth a combined $228M.

Buyers outnumbered sellers: 98 funds opened new AMRI positions and 0 closed out — a net gain of 98 holders — while 0 added to existing stakes and 0 trimmed.

  • 98 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $228M of Albany Molecular Research Inc stock for Q2 2013.
  • 98 funds opened new Albany Molecular Research Inc positions in Q2 2013 and 0 closed out, a net change of +98 holders.

Based on aggregated 13F filings for Q2 2013.